scispace - formally typeset
Z

Zvi Vogel

Researcher at Weizmann Institute of Science

Publications -  127
Citations -  10819

Zvi Vogel is an academic researcher from Weizmann Institute of Science. The author has contributed to research in topics: Receptor & Cannabinoid receptor. The author has an hindex of 46, co-authored 126 publications receiving 10368 citations. Previous affiliations of Zvi Vogel include Israel Institute for Biological Research & Wolfson Medical Center.

Papers
More filters
Journal ArticleDOI

2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

TL;DR: Two types of endogenous cannabinoid-receptor agonists have been identified thus far and an example of a third, ether-type endocannabinoid, 2-arachidonyl glyceryl ether (noladin ether), isolated from porcine brain is reported.
Journal ArticleDOI

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.

TL;DR: The data indicate that the biological activity of 2-Ara-Gl can be increased by related, endogenous 2-acyl-glycerols, which alone show no significant activity in any of the tests employed, suggesting that this effect ('entourage effect') may represent a novel route for molecular regulation of endogenous cannabinoid activity.
Journal ArticleDOI

Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors

TL;DR: In this paper, the C-terminal receptor portions (containing transmembrane domains VI and VII) were exchanged between the alpha 2C-adrenergic and the m3 muscarinic receptor.
Journal ArticleDOI

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

TL;DR: Data indicate that anandamide is an endogenous agonist that may serve as a genuine neurotransmitter for the cannabinoid receptor and was blocked by treatment with pertussis toxin.